Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : TAK crawled time : 12:15 save search
PM360 Magazine Announces Winners of 2021 Trailblazer Awards
Published: 2021-09-24 (Crawled : 12:15) - prnewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.7%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.08%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
awards
Bridge Medicines Enters Exclusive License Agreement with Cornell University for UBR5 Inhibitor Program to Treat Resistant Cancers
Published: 2021-07-28 (Crawled : 12:15) - prnewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.42%
H: 2.14%
C: 1.72%
cancer license
Karyopharm Reports First Quarter 2021 Financial Results and Highlights Recent Company Progress
Published: 2021-05-03 (Crawled : 12:15) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.24%
H: 0.96%
C: 0.6%
KPTI | $1.16 -9.38% -10.34% 1.4M
|
Health Technology
|
| O: -1.56%
H: 3.87%
C: 2.68%
financial results results
Takeda Manufacturing Facilities in Japan and Ireland Recognized With Category Awards for 2021 Facilities of the Year
Published: 2021-04-28 (Crawled : 12:15) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.95%
H: 0.84%
C: 0.48%
Karyopharm Announces European Medicines Agency's Validation of its Type II Variation Marketing Authorization Application for NEXPOVIO®
Published: 2021-04-26 (Crawled : 12:15) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.23%
H: 0.47%
C: -0.53%
KPTI | $1.16 -9.38% -10.34% 1.4M
|
Health Technology
|
| O: -0.11%
H: 5.12%
C: 4.58%
europe authorized application
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.